Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Dutton Report

Very true. Certainly I wouldn't expect them to have inside information but the tone of the report is definitely more upbeat than the last. Perhaps mgmt spoke with them about their vision for the near term and Dutton bought into it. I would not consider that to be inside information. After all Dutton is suppose to offer an independent analysis and those individuals reporting cannot own the stock. That should cover any inside information issues.



"The Firm does not accept any equity compensation. Our principals and analysts are prohibited from owning or trading in securities of covered companies."

Share
New Message
Please login to post a reply